Corcept Therapeutics (CORT) Receivables - Other (2019 - 2025)
Corcept Therapeutics (CORT) has disclosed Receivables - Other for 7 consecutive years, with $4.1 million as the latest value for Q4 2025.
- Quarterly Receivables - Other changed 0.0% to $4.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.1 million through Dec 2025, changed 0.0% year-over-year, with the annual reading at $4.1 million for FY2025, 0.0% changed from the prior year.
- Receivables - Other hit $4.1 million in Q4 2025 for Corcept Therapeutics, up from $3.9 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $18.2 million in Q1 2025 to a low of $900000.0 in Q3 2022.
- Historically, Receivables - Other has averaged $6.1 million across 5 years, with a median of $3.9 million in 2025.
- Biggest YoY gain for Receivables - Other was 1455.56% in 2023; the steepest drop was 87.86% in 2023.
- Year by year, Receivables - Other stood at $1.4 million in 2021, then surged by 900.0% to $14.0 million in 2022, then plummeted by 87.86% to $1.7 million in 2023, then skyrocketed by 141.18% to $4.1 million in 2024, then changed by 0.0% to $4.1 million in 2025.
- Business Quant data shows Receivables - Other for CORT at $4.1 million in Q4 2025, $3.9 million in Q3 2025, and $4.1 million in Q2 2025.